Allucent

Allucent is a contract research organization (CRO). Its solutions cover clinical development, clinical pharmacology, regulatory strategy, drug safety and pharmacovigilance, and government and public health services, and it describes an AI platform called LucentAI that is used in clinical development work.

Its stated customers are small and mid-size biopharmaceutical and biotech companies, which it says it serves with a senior, former-regulator and scientist-led team. The website says the company has worked on more than 825 clinical trials, mostly in oncology, and has a therapeutic focus on oncology, neuroscience, infectious diseases, immunology and inflammation, rare diseases, and cell and gene therapy. Revenue model is service fees for contracted research work, as the site describes project-based delivery.

The company is headquartered in Cary, North Carolina, and lists offices in Houston, Wilmington, Saint-Laurent (Quebec), Sao Paulo, Amsterdam, Bracknell, Cologne, Madrid, Milan, Munich, Paris, Testelt, Bucharest, Budapest, Prague, Sofia, Belgrade, Warsaw, Zagreb, Kyiv, Minsk, Tbilisi, Bangalore, Chennai and Tel Aviv. The website states over 30 years of background and trials in more than 70 countries. Current job postings cover clinical operations, data management, regulatory affairs, pharmacometrics, medical and project leadership roles, with many located in Europe, India and remote in the US and Canada.

Product: Clinical development, clinical pharmacology, regulatory strategy, safety and pharmacovigilance, and government and public health services for drug developers.